Skip to main content
Premium Trial:

Request an Annual Quote


George Church is everywhere. Recently it's been because of his artificial ribosome. This Journal of New England Technology article discusses the ethical implications of creating artificial life. In it, Hastings Center bioethicist Gregory Kaebnick says that Church's work is an extension of current techniques and thus not an instance of "playing God."

Also, though, Church is in the news since Codon Devices, a company that he co-founded with Drew Endy, Jay Keasling, and others, has closed its doors, reports the Boston Globe. At the end of March, board members voted to shut down operations as the company failed to raise additional funds. The Globe says that Codon Devices had raised a total of at least $31 million and had been on lists of most promising start-ups in New England. Blogger Keith Robison had been at Codon Devices, but recently left the company.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.